Description

Heidelberg Pharma The company is a drug development company focused on cancer. 2nd generation ADC technology is our R&D flagship. The company also provides services for the pre-clinical development of new chemical or biological entities. These include drug metabolism- and pharmacokinetic (DMPK) studies and pharmacology services in the field of cancer, inflammatory and autoimmune diseases.

Life Science Sector
Certificates
NO DATA